Nothing changed and an equally inconclusive chest X-ray was followed by a CT scan, which resulted in my diagnosis of IPF. Later I realised I was quite fortunate that my diagnosis was made before I ...

Rein Therapeutics has initiated the randomised RENEW Phase II trial of its Caveolin-1-related peptide, LTI-03, targeting ...

Current idiopathic pulmonary fibrosis (IPF) trials often exclude diverse patient perspectives, leading to unrepresentative conclusions and limited patient engagement. Issues identified include ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced a partnership with Qureight, a ...

a first in IPF patients. Computer tomography (CT) data from the Open Source Imaging Consortium (OSIC) database were analyzed and patient-specific models were generated for two selected cases ...

The Phase 2a, randomized, double-blind, multi-center, placebo-controlled, parallel-design, 2-arm study will enroll approximately 36 subjects with IPF whom will be randomized in a 2:1 ratio for GRI ...